COLD & CO at the Cyclo-Cargologie Forum in Paris : a focus on decarbonised urban logistics

Exposure of Cominarty and Moderna vaccines to room temperature for more than 3 minutes is irreversible as the vaccine is considered thawed. It can’t be re-frozen. In January 2021, the Cold Health Commission “Covid-19” of the « Association Française du Froid » (AFF) published several understanding notes, information and good practices of the cold chain around COVID-19 vaccines. 1.

As a player in food e-commerce, you may be wondering how to maintain the cold chain during the delivery process of your fresh and frozen products. COLD & CO guides you to ensure express home delivery !   The delivery of fresh and frozen products: a problematic in 3 axes The problem of delivering fresh

Since November 9, several laboratories have announced the development of a vaccine that is more than 90% effective. Pfizer-BioNtech laboratories present their first results obtained on a messenger RNA (mRNA) vaccine. What is the principle of this vaccine? What impact on its cold chain ? Historical vaccines with infectious agents Historically, the first vaccines were

The choice between buying / renting a refrigerated transport vehicle and fitting out your van can be a decision with serious consequences for the profitability of your delivery system. COLD & CO advises you. Ask yourself the right questions Before choosing your refrigerated transport method, it is important to learn about the specifics of each system. Study your refrigerated

 COLD & CO offers the CarryTemp XL, a new temperature sorting container that can be integrated into a dry vehicle. The world of frozen food, July 2019   COLD & CO has been developing autonomous and customized isothermal solutions for fifteen years. The specialist works in particular on alternative solutions to the use of a refrigerated truck or

A topical challenge with the upcoming distribution of the COVID-19 vaccine The development and distribution of a COVID-19 vaccine raises several questions about the logistics of distributing health products. The challenge concerns both the number of doses to be dispensed, the countries and manufacturing sites, but also the temperature range to which the product will be